By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists generally agreed that VXUS and SCHE serve different purposes and are not direct substitutes, with VXUS offering diversification and lower volatility, but also exposure to low-growth regions and currency risks, while SCHE provides higher growth potential but also higher volatility and geopolitical risks. The choice between the two depends on the investor's risk tolerance and market outlook.
Risk: Geopolitical risks associated with SCHE's high exposure to China and Taiwan, as well as potential currency headwinds and policy transmission risks from VXUS's heavy weighting in Europe and Japan.
Opportunity: Potential for outsized returns from SCHE if emerging markets earnings recover, and the possibility of VXUS offering resilience during risk-off regimes.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
VXUS provides broad exposure to both developed and emerging markets, whereas SCHE focuses exclusively on emerging markets.
Both funds offer extremely low expense ratios, though VXUS offers a slightly lower fee and a higher dividend yield.
SCHE maintains a more concentrated portfolio, which limits diversification but could lead to greater growth potential.
International investing often involves choosing between broad global coverage and specific regional focuses.
The Vanguard Total International Stock ETF (NASDAQ:VXUS) offers broad non-U.S. diversification across all market tiers, while the Schwab Emerging Markets Equity ETF (NYSEMKT:SCHE) provides targeted, low-cost exposure specifically to developing international economies.
Here’s how the two ETFs stack up on factors like risk, returns, cost, and diversification.
| Metric | VXUS | SCHE | |---|---|---| | Issuer | Vanguard | Schwab | | Expense ratio | 0.05% | 0.07% | | 1-yr return (as of May 18, 2026) | 29.36% | 24.89% | | Dividend yield | 2.76% | 2.67% | | Beta (5Y monthly) | 0.93 | 0.87 | | Assets under management (AUM) | $629.2 billion | $12.3 billion |
VXUS holds a narrow edge in both affordability and income, with a slightly lower expense ratio and higher dividend yield. While the differences are minor, they could be a selling point for cost- and income-focused investors.
| Metric | VXUS | SCHE | |---|---|---| | Max drawdown (5 yr) | -29.44% | -35.73% | | Growth of $1,000 over 5 years (total return) | $1,504 | $1,304 |
SCHE focuses on 2,213 holdings in developing nations, with a 30% allocation to technology stocks, 21% to financial services, and 10% to consumer cyclicals. Its largest positions include Taiwan Semiconductor Manufacturing, Tencent Holdings, and Alibaba Group Holding. This fund launched in 2010 and has a trailing-12-month dividend of $0.94 per share.
VXUS offers much broader diversification through 8,770 holdings, with its largest allocations in financial services (22%), technology (18%), and industrials (16%). Its top holdings include Taiwan Semiconductor Manufacturing, Samsung Electronics, and ASML Holding. This ETF has a trailing-12-month dividend of $2.29 per share.
For more guidance on ETF investing, check out the full guide at this link.
Investing in international stocks can help diversify your portfolio, and both ETFs offer exposure to companies outside the U.S. However, their differences in target markets can appeal to different types of investors.
SCHE’s narrower focus on emerging markets makes it a higher-risk, higher-reward investment. These stocks have plenty of growth potential compared to their more established peers, but they can also be more prone to volatility. While VXUS also covers emerging markets, it’s more diversified with exposure to developed markets, as well.
Over the last five years, SCHE has experienced more severe price fluctuations than VXUS — as evidenced by its deeper max drawdown. While it’s also underperformed VXUS in that time, that doesn’t necessarily mean that it won’t have more room for growth going forward.
Differences in the funds’ sector allocations could also affect your decision. SCHE is more focused on technology, with nearly one-third of its portfolio dedicated to tech stocks. VXUS, on the other hand, primarily targets financial services stocks, with only 18% of assets allocated to tech.
Tech can be volatile at times, but it also has a history of explosive earnings. Whether that’s a risk you’re comfortable with depends on your personal preferences.
Both SCHE and VXUS can provide expansive international exposure. Investors seeking more stability and diversification may prefer VXUS’s focus on both emerging and developed markets. If you’re aiming for higher long-term growth, though, SCHE’s exposure to emerging markets could be a better fit for your portfolio.
Before you buy stock in Schwab Strategic Trust - Schwab Emerging Markets Equity ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Schwab Strategic Trust - Schwab Emerging Markets Equity ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $469,293! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,381,332!
Now, it’s worth noting Stock Advisor’s total average return is 993% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 18, 2026. *
Katie Brockman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML, Taiwan Semiconductor Manufacturing, and Tencent. The Motley Fool recommends Alibaba Group. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"VXUS's developed-market ballast is likely to cap upside more than the article acknowledges, making neither ETF a clear long-term winner without cycle-specific timing."
The article correctly flags VXUS's superior diversification and milder drawdowns versus SCHE's EM-only volatility, yet it understates how VXUS's heavy developed-market weighting (roughly 75%) exposes investors to chronically low-growth regions like Europe and Japan. SCHE's 30% tech tilt and concentrated holdings could deliver outsized returns if EM earnings recover, but the piece ignores current forward P/E discounts in emerging markets versus VXUS holdings. Five-year data already shows SCHE lagging, and geopolitical or currency shocks could widen that gap further.
SCHE's narrower mandate and tech overweight have repeatedly produced sharp rebounds after EM selloffs, and VXUS's broad developed exposure may continue dragging returns if global growth stays anemic.
"The article conflates volatility with risk and omits the structural headwinds (China policy, currency exposure) that explain SCHE's underperformance, making it impossible to assess whether the 5-year gap reflects cyclical weakness or permanent impairment."
This article presents a false choice. VXUS and SCHE aren't substitutes—they're complements with fundamentally different risk profiles. The 5-year data (VXUS +50.4% vs SCHE +30.4%) masks a critical omission: the article doesn't disclose *when* those returns occurred. If emerging markets underperformed because of China regulatory crackdowns (2021-2023) or currency headwinds, that's structural, not cyclical. The 35.73% max drawdown for SCHE versus 29.44% for VXUS is presented as a volatility metric, but the article never quantifies the probability or duration of recovery. Also: SCHE's 2,213 holdings aren't actually concentrated—that's diversified. What matters is *geographic* and *currency* concentration (China + Taiwan = ~40% of SCHE). The dividend yield comparison (2.76% vs 2.67%) is noise given the fee difference is 0.02%.
If emerging markets are entering a multi-year bull run (AI adoption, manufacturing shift from China, India growth), SCHE's underperformance is exactly the setup for mean reversion, making the 'higher risk' framing misleading rather than cautionary.
"Investors must recognize that the performance gap between these ETFs is driven more by currency risk and regional demographic decline than by the specific sector tilts highlighted in the article."
The article presents a classic 'core vs. satellite' choice, but it glosses over the structural risk of the underlying indices. VXUS is a proxy for the MSCI ACWI ex USA, which is currently heavily anchored to Japan and Europe—markets facing chronic demographic stagnation. While SCHE offers higher 'growth' potential via emerging markets, it ignores the geopolitical risk premium inherent in China-heavy portfolios. Investors aren't just choosing between broad and narrow; they are choosing between 'stagnant developed' and 'geopolitically volatile' beta. The 5-year performance gap cited isn't just about sector allocation; it reflects a decade where the U.S. dollar strength and developed market stability crushed emerging market currency returns.
The case against my caution is that emerging markets are currently trading at a multi-year valuation discount relative to developed markets, potentially offering a mean-reversion opportunity that outweighs the geopolitical risk.
"VXUS offers a more robust, lower-risk core international sleeve, while SCHE is a high-conviction EM tilt whose near-term risk may not justify its potential but uncertain upside."
VXUS vs SCHE frames a classic core vs tilt decision. The article highlights cost and breadth, but it glosses over currency and policy risks that disproportionately affect EM (SCHE). SCHE’s -35.73% 5-year max drawdown and tech concentration raise risk for risk-off regimes, even as EM may offer long-run upside. VXUS’s inclusion of developed markets adds resilience when rates rise or if China/regulatory headlines flare, but the article downplays currency drag and valuation dispersion across ex-US markets. The promotional tone around Stock Advisor also biases the reader away from rigorous ETF risk assessment.
If EM normalization occurs and China policy stabilizes, SCHE could surprise to the upside, making the ticket price for EM risk worth paying. In a weaker dollar or global growth pickup, EM stocks could outperform despite current fears.
"VXUS may transmit developed-market policy shocks more directly than the discussion has recognized."
Claude notes structural China risks in SCHE yet overlooks how VXUS's heavy Europe and Japan weighting could transmit ECB or BOJ policy errors into broader drawdowns during synchronized global slowdowns. Currency headwinds already cited by ChatGPT would then compound across both developed and emerging holdings rather than remaining isolated to SCHE's 40% China-Taiwan exposure.
"Volatility magnitude matters less than recovery trajectory in a synchronized downturn; the article omits cycle-timing entirely."
Grok's point about ECB/BOJ policy transmission is valid, but it actually *strengthens* the case for VXUS over SCHE in a synchronized slowdown. If both developed and EM drawdowns occur, VXUS's lower volatility (29.44% vs 35.73% max) means shallower losses during the shock. The real risk nobody flagged: SCHE's rebound speed post-shock. If EM recovers faster than developed markets (as happened 2009-2010), SCHE's higher beta becomes an asset, not a liability. The article frames this as a binary choice when timing the cycle matters more than the choice itself.
"SCHE's heavy China-Taiwan concentration creates a structural anchor that prevents it from capturing a potential broader EM recovery."
Claude assumes SCHE's beta is an asset in recovery, but that ignores the 'China trap.' Unlike 2009, China's current structural deleveraging and demographic decline suggest that a 'fast rebound' is unlikely. SCHE isn't just higher beta; it's higher exposure to state-directed capital allocation. If the next cycle favors India or Southeast Asia, SCHE’s 40% China-Taiwan anchor will act as a permanent drag, regardless of broader EM performance. We are pricing in a recovery that may never arrive.
"SCHE's concentration could trigger outsized tracking error and liquidity risks in crises, potentially worsening losses versus VXUS despite EM upside."
Responding to Gemini: China exposure is indeed a risk, but the bigger practical swing factor is liquidity and tracking error during crises. SCHE’s 40% China-Taiwan weight folds into a market-cap index with fewer liquid large-cap names; in a risk-off jitter, forced selling and ETF redemption could widen tracking error, magnifying losses beyond the apparent beta. VXUS would still have more breadth; this could matter in a drawdown regime even if EM rebounds later.
The panelists generally agreed that VXUS and SCHE serve different purposes and are not direct substitutes, with VXUS offering diversification and lower volatility, but also exposure to low-growth regions and currency risks, while SCHE provides higher growth potential but also higher volatility and geopolitical risks. The choice between the two depends on the investor's risk tolerance and market outlook.
Potential for outsized returns from SCHE if emerging markets earnings recover, and the possibility of VXUS offering resilience during risk-off regimes.
Geopolitical risks associated with SCHE's high exposure to China and Taiwan, as well as potential currency headwinds and policy transmission risks from VXUS's heavy weighting in Europe and Japan.